Poly--Glutamic Acid Attenuates Angiogenesis and Inflammation in Experimental Colitis
Figure 5
MPO activity in a γ-PGA-treated DSS-induced colitis model. Control group (without DSS; Cont), 3% DSS administration group (DSS), 3% DSS with γ-PGA at 50 mg/kg body weight per day (D + P50), 3% DSS with γ-PGA at 200 mg/kg body weight per day (D + P200). Data shown represent the results of 3 independent experiments, expressed as mean ± SD ( per group). *, DSS versus Cont; #, D + P50 and D + P200 versus DSS.
